AFAO Health Promotion Officer, Sean Slavin, blogs live from CROI 2015:
Amidst all the excitement at #CROI2015 about pre-exposure prophylaxis (PrEP), a session this afternoon on post-exposure prophylaxis (PEP) - 'PEP: Remember Me?' - was an important reminder that this prevention technology should not be forgotten.
Friday, 27 February 2015
Hepatitis C: "Mission accomplished"? (CROI 2015 Day 4)
AFAO Health Promotion Officer, Sean Slavin, blogs live from CROI 2015:
A cure for hepatitis C? "Mission accomplished" is the message from #CROI2015, as a range of new drugs demonstrate high efficacy with minimal side effects. A number of these have been approved for use in the US.
Implementation, however, is in its infancy and there are currently significant cost barriers with the drug manufacturers struggling to demonstrate cost effectiveness at current prices.In recent weeks competitive bidding began in the US between rival manufacturers and prices are expected to fall as more agents come onto the market.
A cure for hepatitis C? "Mission accomplished" is the message from #CROI2015, as a range of new drugs demonstrate high efficacy with minimal side effects. A number of these have been approved for use in the US.
Implementation, however, is in its infancy and there are currently significant cost barriers with the drug manufacturers struggling to demonstrate cost effectiveness at current prices.In recent weeks competitive bidding began in the US between rival manufacturers and prices are expected to fall as more agents come onto the market.
Thursday, 26 February 2015
HIV and lung cancer: smoking is a greater risk than HIV (CROI 2015 Day 3)
AFAO Health Promotion Officer, Sean Slavin, blogs live from CROI 2015:
In a session today at #CROI2015 on cancer and HIV, lung cancer was highlighted as one of the most prevalent among people with HIV.
In a session today at #CROI2015 on cancer and HIV, lung cancer was highlighted as one of the most prevalent among people with HIV.
PrEP and women: low adherance highlights stigma and gender inequality (CROI 2015 Day 2)
AFAO Health Promotion Officer, Sean Slavin, blogs live from CROI 2015:
One of the most interesting papers at #CROI2015 today was about the failure of Tenofovir gel as PrEP for women in the South African FACTS 001 trial. This study, among young, poor women showed that adherence is indeed a challenge and not necessarily because of any failure of the participants.
One of the most interesting papers at #CROI2015 today was about the failure of Tenofovir gel as PrEP for women in the South African FACTS 001 trial. This study, among young, poor women showed that adherence is indeed a challenge and not necessarily because of any failure of the participants.
Good news on PrEP for gay men (CROI 2015 Day 1)
The annual Conference on Retroviruses and Opportunistic Infections (CROI 2015) is being held in Seatle from 23-26 February. AFAO Health Promotion Officer Sean Slavin is blogging live from Seattle, reflecting on some of the key highlights:
Subscribe to:
Posts (Atom)